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D E S C R I P T I O N  o f  C A S E
The patient, a two-month-old Gambian infant, was one of twins born in November 2003. In the latter part of her pregnancy, the patient’s mother went to stay 
with her family in southern Senegal, where she delivered at 
uncertain gestation in a village health centre. The patient, 
a 1.75-kg girl, and her sibling, a 2.4-kg boy, were both born 
alive. Soon after delivery the twins’ mother died. The cause of 
her death is not known.
The twins were brought from Senegal to Gambia, where 
the second twin died, again of an unknown cause. The 
patient was cared for by an aunt who, being unable to lactate, 
attempted to feed her with an infant formula intended for use 
beyond six months of age, though the limited ﬁ nancial means 
of the family made this difﬁ cult. The patient was admitted 
to the Royal Victoria Teaching Hospital in Gambia at seven 
weeks of age with a history of fever and generalised oedema. 
On examination the patient looked unwell, was grossly 
oedematous, and weighed 2.3 kg (Figure 1). She was alert 
and had no evidence of neurological abnormality. A low-
grade pyrexia was present, but there were no other abnormal 
physical ﬁ ndings. 
What Are the Likely Causes of This Presentation 
and Which Tests Would You Perform?
For any sick young infant in any setting, the possibility of 
infection must be foremost in the clinician’s mind. Neonates 
and young infants are particularly susceptible to infection, 
the more so when they are low birth weight and suffering 
from malnutrition, as must be suspected in a motherless 
child in this setting. Bacterial infections top the list, with 
group B streptococcus, gram-negative organisms (such as 
Escherichia coli), pneumococcus, Haemophilus inﬂ uenzae type 
b, and Staphylococcus aureus being common pathogens. A 
systematic search for a focus of infection is needed because 
young infants localise infections poorly and present with 
non-speciﬁ c symptoms and signs. While respiratory distress 
may indicate pneumonia, a swollen joint may indicate septic 
arthritis, and a bulging fontanelle, seizures, and depressed 
level of consciousness may indicate meningitis, these signs 
cannot be relied upon. A sepsis work-up in any sick young 
infant should include, regardless of signs, microscopy and 
culture of urine and cerebrospinal ﬂ uid (CSF), blood culture, 
and a chest radiograph as well as swabs of suspect lesions. 
In endemic countries malaria is uncommon in very 
young infants, in part because of the presence of maternal 
antibodies and high levels of fetal haemoglobin, but 
nevertheless a blood ﬁ lm is appropriate to rule out malaria. 
HIV infection must be considered in this sick infant whose 
mother and sibling have died. Without intervention, mother-
to-child transmission of HIV-1 occurs during pregnancy and 
delivery in 15–30 percent of infants and via breast-milk in 10–
20 percent [1]. Perinatally acquired HIV progresses rapidly 
in up to 25 percent of infants and usually presents with 
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Figure 1. Photographs of the Patient Soon after Admission, Showing 
Generalised Oedema
(A) shows the frontal view. (B) and (C) demonstrate oedema of the back.
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non-speciﬁ c features. Malnutrition, diarrhoea, pneumonia, 
dermatitis, lymphadenopathy, hepatosplenomegaly, oral 
candidiasis, and parotitis are among the commoner features. 
The diagnosis of HIV infection in infants is complicated 
by the passive transfer of maternal anti-HIV antibodies. 
Antibody-based testing cannot reliably conﬁ rm infection 
until the infant is 18 months old. However, polymerase chain 
reaction testing to detect the presence of HIV DNA can 
conﬁ rm infection in the early stages.
The differential diagnosis of pyrexia in an infant in the 
tropics includes a range of other infections, including 
tuberculosis and salmonellosis, the likelihood of which will be 
inﬂ uenced by local epidemiology and speciﬁ c features of the 
presentation. 
In this case, oedema was the major feature that 
accompanied the pyrexia and it requires explanation as 
it is unusual in young infants. Heart failure is a cause of 
generalised oedema but will be accompanied by other signs 
such as tachypnoea, cardiomegaly, hepatomegaly, and often 
a heart murmur, all of which were absent in this case. Renal 
causes such as nephrotic syndrome are unlikely. In this 
setting, an infant whose mother has died is very much at risk 
of malnutrition. Kwashiorkor, a less common manifestation of 
malnutrition in young infants than marasmus, is one possible 
explanation for the oedema in this case, though the severity 
and transience of it would be unusual. Basic anthropometry 
(weight, length/height, weight-for-length/height z-score) 
should be routine in the assessment of sick children, though 
anthropometry may not indicate malnutrition when the 
patient has oedema (as in this case where the z-score was 
above the median). Transient oedema can also be a feature of 
African trypanosomiasis.
The child was treated for malnutrition with appropriate 
nutritional support and broad-spectrum antibiotics. The 
sepsis work-up was negative, but on a routine thick blood ﬁ lm, 
which was negative for malaria parasites, the microscopist was 
surprised to see numerous extracellular ﬂ agellate parasites, 
identiﬁ ed by a senior colleague as trypanosomes. The child 
was referred to the Medical Research Council Laboratories 
hospital in Gambia for further management. Tests for HIV-1 
and HIV-2, both antibodies (Murex HIV-1.2.0, Abbott-Murex) 
and polymerase chain reaction, were negative.
What Are the Most Important Complications of Human 
African Trypanosomiasis? How Can the Diagnosis of 
Human African Trypanosomiasis Be Conﬁ rmed? 
Human African Trypanosomiasis (HAT), also known as 
sleeping sickness, is caused by Trypanosoma brucei rhodesiense 
(in East and Southern Africa) or Trypanosoma brucei gambiense 
(in West and Central Africa). Infection with T. b. gambiense 
was ﬁ rst described by Dutton in 1902 (Figure 2) in Gambia 
in a riverboat captain by the name of Kelly. Although it has 
re-emerged in several countries in sub-Saharan Africa, it has 
not been seen in Gambia, Senegal, or Guinea-Bissau for more 
than 20 years [2]. 
Disease due to T. b. rhodesiense progresses rapidly over 
weeks, while disease due to T. b. gambiense tends to progress 
more slowly over months. In either case, infection leads to 
invasion of the central nervous system (CNS) and death 
if untreated. The two subspecies are morphologically 
indistinguishable. Fortunately, from the point of view of 
diagnosis, their geographical distribution does not overlap, 
though there is now concern about geographical convergence 
in Uganda [3]. 
The diagnosis of HAT caused by T. b. gambiense presents 
different challenges from that caused by T. b. rhodesiense, 
which is usually directly detectable in the blood. A stepwise 
approach to the diagnosis of T. b. gambiense starts with 
a serological test such as the card agglutination test for 
trypanosomiasis (CATT), a ﬁ eld diagnostic test of high 
sensitivity but lower speciﬁ city (due to cross-reactivity with 
animal trypanosomes), followed by parasitological diagnosis 
from blood or lymph samples. In T. b. gambiense infections, 
detection of trypanosomes in blood is difﬁ cult, given the 
low-level and intermittent parasitaemia. In both cases, 
detection of parasites in blood or lymph node samples or 
clinical suspicion alone mandates examination of the CSF 
to determine the presence of CNS disease (late-stage HAT). 
Parasites can easily be missed on microscopy of a simple wet 
preparation of CSF, and sensitivity is increased by examining 
a doubly centrifuged specimen. The presence of CSF 
trypanosomes or a CSF white cell count of >5 cells per mm3 is 
diagnostic of late-stage trypanosomiasis.
In this case a second blood ﬁ lm at the Medical Research 
Council Laboratories hospital conﬁ rmed the presence of 
numerous trypanosomes. A CSF sample was blood-stained and 
showed trypanosomes on a wet preparation. A CSF sample 
repeated ﬁ ve days later, before any speciﬁ c treatment was 
given, showed again the presence of occasional trypanosomes. 
This specimen was not blood-stained and showed no 
pleocytosis. The ﬁ nding of live trypanosomes in two CSF 
samples taken ﬁ ve days apart suggests that the CNS had been 
invaded, although no neurological abnormalities were found. 
It is not certain whether this invasion was spontaneous or a 
result of seeding from the ﬁ rst lumbar puncture.
What Treatment Is Indicated for HAT?
In the absence of CNS involvement (i.e., in early-stage HAT), 
pentamidine is the drug of choice for infection with T. b. 
gambiense while suramin is indicated for T. b. rhodesiense. 
Pentamidine is associated with cure rates above 90 percent 
in T. b. gambiense infection [4]. Hypotension is the chief 
immediate adverse drug reaction, occurring more frequently 
when administered intravenously than intramuscularly, 
but pentamidine also causes potentially severe adverse 
effects such as hypoglycaemia, hypocalcaemia, renal failure, 
neutropenia, and ventricular arrhythmia, all of which make 
it an unattractive option for treating an infant. In T. b. 
DOI: 10.1371/journal.pmed.0030355.g002
Figure 2. Watercolour of T. b. gambiense from the Original 
Description of the First Patient by J. E. Dutton, Gambia, 1902. 
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rhodesiense infection, treatment failures with pentamidine are 
common, making suramin the drug of choice for early-stage 
disease. 
Both pentamidine and suramin penetrate CSF poorly; 
therefore, given the presence of CSF trypanonosomes in 
this case, the alternatives for the treatment of presumptive 
T. b. gambiense infection were eﬂ ornithine or melarsoprol. 
Eﬂ ornithine is a trypanostatic drug associated with bone 
marrow suppression in up to half of recipients, though 
this usually resolves at the end of treatment. Melarsoprol 
is a trivalent arsenical drug that is highly trypanocidal, but 
also causes a potentially fatal encephalopathy in ﬁ ve to 
ten percent of patients. Eﬂ ornithine needs to be given six-
hourly intravenously for 14 days, which is impractical in a 
developing-world setting, and the dose for an infant is not 
well established. Melarsoprol was the only practical option; 
therefore, despite its potential toxicity, it was given at a 
dose of 2.2 mg/kg daily intravenously for ten days, along 
with prednisolone (1 mg/kg daily) to reduce the risk of 
melarsoprol-induced encephalopathy [5,6].
Was This Case T. b. gambiense HAT?
Conﬁ rmed infection with a trypanosome should be regarded 
as HAT until proven otherwise. In this case, the thin blood 
ﬁ lm done to examine the morphology of the trypanosome 
raised a doubt that was not resolved one way or the other 
until after the acute management of the patient. The 
appearance of the parasites was not typical of T. b. gambiense 
(Figure 2), but was typical of rodent trypanosomes of the 
subgenus T. (Herpetosoma) (Figure 3). Antibodies to T. b. 
gambiense were not detected in blood or CSF by ﬂ uorescent 
antibody testing. Sequencing of part of the 18S ribosomal 
RNA conﬁ rmed a genotype quite distinct from that of T. b. 
gambiense but very similar to that of the T. (Herpetosoma) group, 
particularly T. lewisi, from which it differed by just one base 
(Figure 4) [7]. Molecular methods may become increasingly 
important in the diagnosis and management of HAT if there 
is, as feared, convergence of the geographical ranges of T. b. 
gambiense and T. b. rhodesiense [3].
Progress
The patient’s oedema resolved without speciﬁ c treatment 
over the course of a week, and she remained clinically 
stable until therapy with melarsoprol was started. A repeat 
blood ﬁ lm the day before starting treatment, 15 days after 
initial presentation, showed a persistent high density of 
trypanosomes. Three days into treatment a blood ﬁ lm showed 
no evidence of trypanosomes. Treatment was well tolerated: 
apart from a temperature of up to 38 °C early in the course 
of treatment, a well-described phenomenon, the patient 
remained well and had no signs of encephalopathy [8]. 
Repeat blood ﬁ lm and CSF samples taken at the completion 
of treatment and ten months later showed no evidence of 
parasites, and there were no white cells in the CSF. Follow-
up to 13 months of age conﬁ rmed that the child was making 
normal developmental progress.
Visits were made to the family homes in Gambia and 
Senegal. The caregiver’s house in rural Gambia was 
reportedly infested with rodents, which was conﬁ rmed by the 
ﬁ nding of rodent droppings on the bed where the patient 
slept and a dead rodent on the porch. The mother’s home 
also reportedly had a rodent problem, but there was no 
report of this in her family’s home in Senegal.
Two live rodents of unidentiﬁ ed species were trapped at 
the caregiver’s home. Examination of a blood ﬁ lm revealed 
trypanosomes morphologically identical to those seen in the 
patient. Genotyping of a part of the 18S ribosome revealed 
a sequence differing by two bases from that of the patient’s 
parasite (Figure 4), which may well represent variation within 
the species rather than a different species [9]. A blood ﬁ lm of 
the caregiver showed no evidence of trypanosomes.
D I S C U S S I O N
This unique case has provided the opportunity to review 
approaches to the unwell young infant in general and 
the management of suspected HAT in particular. To our 
knowledge, this is the ﬁ rst documented case of an infection 
by trypanosomes of the subgenus T. (Herpetosoma) in humans 
in Africa, and the ﬁ rst case anywhere in which this parasite 
has been able to infect the CNS and survive. As such, it offers 
the opportunity to review what is known of this parasite, and 
to consider the environmental, host-related, and organism-
related factors that may have resulted in the child’s illness. 
The subgenus T. (Herpetosoma) comprises at least 45 
morphologically identical species that infect rodents 
throughout the world [10,11]. T. lewisi, the archetype of the 
subgenus, is a parasite of the genus Rattus and is transmitted 
via the excreta of ﬂ eas. In West Africa there are records of T. 
(Herpetosoma) infection in members of the genera Cricetomys 
(Gambian giant rat) and Mastomys (multimammate rat) as 
well as in Rattus itself [12]. 
There are, to our knowledge, only three reported cases 
of human infection with a T. lewisi–like parasite, though 
in the absence of expert microscopy other cases might be 
DOI: 10.1371/journal.pmed.0030355.g003
Figure 3. Thin Blood Film of the Patient Showing Five Trypanosomes 
and Several Red Blood Cells
Arrows indicate the pointed posterior segment (small arrow) and 
the large kinetoplast (large arrow) that distinguish these from T. b. 
gambiense. 
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misdiagnosed. All reported cases occurred in Asia, and all 
were reliant on morphology for species identiﬁ cation. 
The ﬁ rst patient, described in 1933, was a four-month-old 
Malaysian child who lived in a rat-infested dwelling [13]. 
The child presented with fever and lassitude associated with 
a heavy parasitaemia with T. lewisi. No CSF investigation was 
reported. The parasitaemia and accompanying symptoms 
resolved without speciﬁ c treatment after ﬁ ve days. Blood ﬁ lms 
from other family members were all negative. One rat caught 
in the dwelling had a heavy infection with a morphologically 
identical parasite. This patient was followed up years later and 
found to have no trace of the parasite in blood or CSF [14]. 
The second report (of two cases) was from India in 1974 
[15]. An adult couple who lived in a rat-infested village both 
presented with fever and one had malaise. Both were found 
to have heavy T. lewisi parasitaemia. Symptoms resolved 
without speciﬁ c treatment after two to three days. Repeat 
blood ﬁ lms taken eight weeks later were negative. 
In the present case, the parasitaemia persisted unabated for 
more than two weeks until speciﬁ c therapy was started, unlike 
the Malaysian infant reported by Johnson [13]. Neither was 
oedema a feature of previous cases, though it is characteristic 
of HAT and it is conceivable that T. lewisi infection caused the 
oedema in this case. 
It is unclear in this case whether infection was acquired 
antenatally or postnatally. Congenital infections with T. b. 
gambiense and T. b. rhodesiense have been documented [10]. 
The usual duration of the incubation period of T. b. gambiense 
is in the order of months, whereas T. (Herpetosoma) infections 
develop detectable parasitaemias typically within seven to 
14 days of inoculation in rodents. There is no evidence 
that T. (Herpetosoma) trypanosomes can be transmitted 
transplacentally in rodents [16]. This suggests that in 
our patient, transmission occurred after delivery through 
exposure to the excreta of infected ﬂ eas in the environment 
in which the child was living. 
Host factors are likely to have been important in this case: 
the relative immune vulnerability of early infancy together 
with malnutrition probably increased this child’s susceptibility 
to this unusual infection. Humans naturally resist infection by 
animal trypanosomes such as T. brucei, T. lewisi, T. congolense, 
and T. vivax. What drives this resistance of human serum 
to animal trypanosomes has been debated, but recent 
research suggests that for T. brucei it is an apolipoprotein, 
either a haptoglobin-related protein or apolipoprotein L-I 
[17,18]. Whether similar factors are important in controlling 
infections with T. lewisi is unknown. 
Organism factors may also have played a part in this case. 
It is possible that this patient’s parasite has become better 
adapted to human infection than its forebears, though we 
cannot say this with certainty. Virulence varies between 
subspecies of T. brucei: T. b. rhodesiense is more virulent than 
T. b. gambiense, arguably killing its host too rapidly for its own 
interest. This is related to the serum resistance–associated 
SRA gene, which is now used for the molecular epidemiology 
of T. b. rhodesiense infections and, as its name implies, is 
associated with resistance to human serum in vitro and in 
vivo [3]. The continuing adaptation of organisms to human 
infection will be inﬂ uenced by changing host factors, and in 
this respect there is concern that the HIV pandemic might 
create a new window of opportunity for organisms to make 
this transition [19].
Conclusion
The lessons from this learning forum are several. Firstly, 
infection is a major cause of mortality in young infants and 
must be managed diligently with a thorough search for its 
cause and the institution of appropriate treatment. Secondly, 
HAT remains a potentially fatal disease that presents 
challenges in the difﬁ culty of its diagnosis and in the toxicity 
of its treatments. Additionally, given the right combination 
of environmental, host-related, and organism-related factors, 
a normally harmless organism can emerge as a human 
pathogen. This ﬁ rst report of invasive disease from T. lewisi 
shows that this parasite cannot be dismissed as a harmless 
cause for false positives in the work-up of suspected cases 
of HAT. We believe that on current evidence this infection 
should be treated when diagnosed. However, the data on 
which to make this decision are limited, so in asymptomatic 
conﬁ rmed cases without CNS invasion a case can be made 
for careful follow-up without treatment. Nevertheless, the 
ﬁ nal message must be that if there is any evidence of invasive 
disease, any doubt concerning the identity of the parasite, or 
any concern regarding the effectiveness of follow-up, standard 
treatment for HAT should not be delayed. 
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Learning Points
• Infection is a major cause of mortality in young infants and 
requires a thorough search for its cause and the institution of 
appropriate treatment.
• HAT remains a potentially fatal disease that can be challenging 
to diagnose. 
• Treatments for HAT are associated with toxicities (e.g., 
pentamidine can cause hypotension, eﬂ ornithine can 
cause bone marrow suppression, melarsoprol can cause 
encephalopathy).
• Given the right combination of environmental, host-related, 
and organism-related factors, a normally harmless organism 
can emerge as a human pathogen.
• If in doubt, treat human infection with non-typical 
trypanosomes as HAT.
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